# Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument

> **NCT06499454** · — · NOT_YET_RECRUITING · sponsor: **Ruby Robotics Inc** · enrollment: 50 (estimated)

## Conditions studied

- Lung Cancer
- Lung Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Ruby ROSE evaluation

## Key facts

- **NCT ID:** NCT06499454
- **Lead sponsor:** Ruby Robotics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499454, "Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06499454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*